Economic Burden of Dengue Virus Infection at the Household Level Among Residents of Puerto Maldonado, Peru

Overview

Journal Am J Trop Med Hyg

Specialty Tropical Medicine

Date 2015 Jul 29

PMID 26217040

Citations 6

Authors

Gabriela Salmon-Mulanovich

David L Blazes

Andres G Lescano

Daniel G Bausch

Joel M Montgomery

William K Pan

Affiliations

Soon will be listed here.

Abstract

Dengue virus (DENV) was reintroduced to Peru in the 1990s and has been reported in Puerto Maldonado (population ~65,000) in the Peruvian southern Amazon basin since 2000. This region also has the highest human migration rate in the country, mainly from areas not endemic for DENV. The objective of this study was to assess the proportion of household income that is diverted to costs incurred because of dengue illness and to compare these expenses between recent migrants (RMs) and long-term residents (LTRs). We administered a standardized questionnaire to persons diagnosed with dengue illness at Hospital Santa Rosa in Puerto Maldonado from December 2012 to March 2013. We compared direct and indirect medical costs between RMs and LTRs. A total of 80 participants completed the survey, of whom 28 (35%) were RMs and 52 (65%) were LTRs. Each dengue illness episode cost the household an average of US$105 (standard deviation [SD] = 107), representing 24% of their monthly income. Indirect costs were the greatest expense (US$56, SD = 87), especially lost wages. The proportion of household income diverted to dengue illness did not differ significantly between RM and LTR households. The study highlights the significant financial burden incurred by households when a family member suffers dengue illness.

Citing Articles

Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems.

Okesanya O, Amisu B, Adigun O, Ahmed M, Agboola A, Kab T Trop Dis Travel Med Vaccines. 2025; 11(1):1.

PMID: 39748388 PMC: 11694362. DOI: 10.1186/s40794-024-00236-x.

Cost of controlling the dengue vector Aedes aegypti in the Peruvian amazon.

Durand S, Paredes A, Pacheco C, Fernandez R, Herrera J, Cabezas C Rev Peru Med Exp Salud Publica. 2024; 41(1):46-53.

PMID: 38808844 PMC: 11149769. DOI: 10.17843/rpmesp.2024.411.12905.

Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands.

Feldstein L, Ellis E, Rowhani-Rahbar A, Hennessey M, Staples J, Halloran M PLoS Negl Trop Dis. 2019; 13(7):e0007563.

PMID: 31323020 PMC: 6668848. DOI: 10.1371/journal.pntd.0007563.

Predictors of mitochondrial DNA copy number and damage in a mercury-exposed rural Peruvian population near artisanal and small-scale gold mining: An exploratory study.

Berky A, Ryde I, Feingold B, Ortiz E, Wyatt L, Weinhouse C Environ Mol Mutagen. 2018; 60(2):197-210.

PMID: 30289587 PMC: 6452630. DOI: 10.1002/em.22244.

Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine.

El Fezzazi H, Branchu M, Carrasquilla G, Pitisuttithum P, Perroud A, Frago C Am J Trop Med Hyg. 2017; 97(6):1898-1903.

PMID: 29141713 PMC: 5805027. DOI: 10.4269/ajtmh.16-0952.

References

Morrison A, Minnick S, Rocha C, Forshey B, Stoddard S, Getis A . Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis. 2010; 4(5):e670. PMC: 2864256. DOI: 10.1371/journal.pntd.0000670. View

Shepard D, Coudeville L, Halasa Y, Zambrano B, Dayan G . Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011; 84(2):200-7. PMC: 3029168. DOI: 10.4269/ajtmh.2011.10-0503. View

Paz-Soldan V, Plasai V, Morrison A, Rios-Lopez E, Guedez-Gonzales S, Grieco J . Initial assessment of the acceptability of a Push-Pull Aedes aegypti control strategy in Iquitos, Peru and Kanchanaburi, Thailand. Am J Trop Med Hyg. 2011; 84(2):208-17. PMC: 3029169. DOI: 10.4269/ajtmh.2011.09-0615. View

Lee B, Connor D, Kitchen S, Bacon K, Shah M, Brown S . Economic value of dengue vaccine in Thailand. Am J Trop Med Hyg. 2011; 84(5):764-72. PMC: 3083745. DOI: 10.4269/ajtmh.2011.10-0624. View

Alcalde-Rabanal J, Lazo-Gonzalez O, Nigenda G . [The health system of Peru]. Salud Publica Mex. 2011; 53 Suppl 2:s243-54. View

Halasa Y, Shepard D, Zeng W . Economic cost of dengue in Puerto Rico. Am J Trop Med Hyg. 2012; 86(5):745-752. PMC: 3335675. DOI: 10.4269/ajtmh.2012.11-0784. View

Tam P, Dat N, Huu L, Thi X, Duc H, Tu T . High household economic burden caused by hospitalization of patients with severe dengue fever cases in Can Tho province, Vietnam. Am J Trop Med Hyg. 2012; 87(3):554-8. PMC: 3435363. DOI: 10.4269/ajtmh.2012.12-0101. View

Durbin A, Whitehead S . The dengue human challenge model: has the time come to accept this challenge?. J Infect Dis. 2012; 207(5):697-9. DOI: 10.1093/infdis/jis749. View

Durbin A, Kirkpatrick B, Pierce K, Elwood D, Larsson C, Lindow J . A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial. J Infect Dis. 2013; 207(6):957-65. PMC: 3571448. DOI: 10.1093/infdis/jis936. View

10.

Castro Rodriguez R, Galera-Gelvez K, Lopez Yescas J, Rueda-Gallardo J . Costs of dengue to the health system and individuals in Colombia from 2010 to 2012. Am J Trop Med Hyg. 2015; 92(4):709-714. PMC: 4385762. DOI: 10.4269/ajtmh.14-0386. View

11.

Endy T, Chunsuttiwat S, Nisalak A, Libraty D, Green S, Rothman A . Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002; 156(1):40-51. DOI: 10.1093/aje/kwf005. View

12.

da Gloria Teixeira M, Barreto M, Costa M, Ferreira L, Vasconcelos P, Cairncross S . Dynamics of dengue virus circulation: a silent epidemic in a complex urban area. Trop Med Int Health. 2002; 7(9):757-62. DOI: 10.1046/j.1365-3156.2002.00930.x. View

13.

Whitehead S, Falgout B, Hanley K, Blaney Jr J, Markoff L, Murphy B . A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. J Virol. 2002; 77(2):1653-7. PMC: 140839. DOI: 10.1128/jvi.77.2.1653-1657.2003. View

14.

Northridge M, Sclar E . A joint urban planning and public health framework: contributions to health impact assessment. Am J Public Health. 2003; 93(1):118-21. PMC: 1447705. DOI: 10.2105/ajph.93.1.118. View

15.

Wagstaff A, Watanabe N . What difference does the choice of SES make in health inequality measurement?. Health Econ. 2003; 12(10):885-90. DOI: 10.1002/hec.805. View

16.

Braks M, Honorio N, Lourencqo-De-Oliveira R, Juliano S, Lounibos L . Convergent habitat segregation of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) in southeastern Brazil and Florida. J Med Entomol. 2004; 40(6):785-94. DOI: 10.1603/0022-2585-40.6.785. View

17.

Gubler D . The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?. Comp Immunol Microbiol Infect Dis. 2004; 27(5):319-30. DOI: 10.1016/j.cimid.2004.03.013. View

18.

Lloyd L, Winch P, Kendall C . Results of a community-based Aedes aegypti control program in Merida, Yucatan, Mexico. Am J Trop Med Hyg. 1992; 46(6):635-42. DOI: 10.4269/ajtmh.1992.46.635. View

19.

Phillips I, Need J, Escamilla J, Colan E, Sanchez S, Rodriguez M . First documented outbreak of dengue in the Peruvian Amazon region. Bull Pan Am Health Organ. 1992; 26(3):201-7. View

20.

Murray C, Lopez A . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061):1269-76. DOI: 10.1016/S0140-6736(96)07493-4. View